Finance

Max Keiser Reveals Epic Bitcoin Prediction for Old ‘New’ El Salvador President By U.Today

U.Today - Nayib Bukele started his second term as President of El Salvador yesterday, continuing his administration's pioneering efforts in cryptocurrency adoption. Since...

Mexico historic election largely overshadowed by violence

Former Mexico City mayor Claudia Sheinbaum speaks after being named presidential candidate of the ruling Morena party for next year's presidential election in...

Qatar Airways closes in on major Boeing, Airbus widebody order, Bloomberg News reports By Reuters

(Reuters) - Qatar Airways PJSC is nearing a decision on a major widebody order split between Boeing (NYSE:) and Airbus, Bloomberg News...

JPMorgan to expand AI tool to help portfolio managers ‘correct for bias’

Artificial intelligence is increasingly playing a role in helping with investment decisions at top asset managers, and that includes the biggest bank by...

Nvidia announces new AI chips as market competition heats up

Jensen Huang, co-founder and chief executive officer of Nvidia Corp., during the Nvidia GPU Technology Conference (GTC) in San Jose, California, US, on...

Wall Street dives into Amazon’s robust cloud and AI strategy By Investing.com

OverviewAmazon.com, Inc. (NASDAQ: NASDAQ:) continues to excel as a leading force in e-commerce, cloud computing, digital streaming, and artificial intelligence. Recent analyses from...

Nippon Steel’s Mori returns to US this week for talks on US Steel takeover By Reuters

By Yuka Obayashi, Katya Golubkova and Ritsuko Shimizu TOKYO (Reuters) - Nippon Steel's vice chairman plans to return to the United States...

Merus Presents Interim Data on MCLA-145 Monotherapy and in Combination with Pembrolizumab at the 2024 ASCO ® Annual Meeting By Investing.com

UTRECHT, The Netherlands and CAMBRIDGE, Mass., June 02, 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: NASDAQ:) (Merus, the Company, we, or our), a...

Belantamab Mafodotin combination reduced the risk of disease progression or death by nearly 50% versus standard of care combination in relapsed/refractory multiple myeloma

DREAMM-8 phase III trial showed statistically significant and clinically meaningful improvement in primary endpoint of progression-free survival (PFS)Median PFS not yet reached at...
1...9,0649,0659,066...9,260Page 9,065 of 9,260

Latest articles

spot_imgspot_img